|
1
|
Scanlan MJ, Gure AO, Jungbluth AA, Old LJ
and Chen YT: Cancer/testis antigens: An expanding family of targets
for cancer immunotherapy. Immunol Rev. 188:22–32. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scanlan MJ, Simpson AJ and Old LJ: The
cancer/testis genes: Review, standardization, and commentary.
Cancer Immun. 4:12004.PubMed/NCBI
|
|
3
|
Simpson AJ, Caballero OL, Jungbluth A,
Chen YT and Old LJ: Cancer/testis antigens, gametogenesis and
cancer. Nat Rev Cancer. 5:615–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zendman AJ, Ruiter DJ and Van Muijen GN:
Cancer/testis-associated genes: Identification, expression profile,
and putative function. J Cell Physiol. 194:272–288. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen YT, Scanlan MJ, Sahin U, Türeci O,
Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M and Old
LJ: A testicular antigen aberrantly expressed in human cancers
detected by autologous antibody screening. Proc Natl Acad Sci USA.
94:1914–1918. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song MH, Choi KU, Shin DH, Lee CH and Lee
SY: Identification of the cancer/testis antigens AKAP3 and CTp11 by
SEREX in hepatocellular carcinoma. Oncol Rep. 28:1792–1798.
2012.PubMed/NCBI
|
|
7
|
Chen YT, Chadburn A, Lee P, Hsu M, Ritter
E, Chiu A, Gnjatic S, Pfreundschuh M, Knowles DM and Old LJ:
Expression of cancer testis antigen CT45 in classical Hodgkin
lymphoma and other B-cell lymphomas. Proc Natl Acad Sci USA.
107:3093–3098. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song MH, Ha JM, Shin DH, Lee CH, Old L and
Lee SY: KP-CoT-23 (CCDC83) is a novel immunogenic cancer/testis
antigen in colon cancer. Int J Oncol. 41:1820–1826. 2012.PubMed/NCBI
|
|
9
|
Song MH, Ha JC, Lee SM, Park YM and Lee
SY: Identification of BCP-20 (FBXO39) as a cancer/testis antigen
from colon cancer patients by SEREX. Biochem Biophys Res Commun.
408:195–201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fratta E, Coral S, Covre A, Parisi G,
Colizzi F, Danielli R, Nicolay HJ, Sigalotti L and Maio M: The
biology of cancer testis antigens: Putative function, regulation
and therapeutic potential. Mol Oncol. 5:164–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ong SE and Mann M: A practical recipe for
stable isotope labeling by amino acids in cell culture (SILAC). Nat
Protoc. 1:2650–2660. 2006. View Article : Google Scholar
|
|
12
|
Dobrynin P, Matyunina E, Malov SV and
Kozlov AP: The novelty of human cancer/testis antigen encoding
genes in evolution. Int J Genomics. 2013:1051082013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Doyle JM, Gao J, Wang J, Yang M and Potts
PR: MAGE-RING protein complexes comprise a family of E3 ubiquitin
ligases. Mol Cell. 39:963–974. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Epping MT, Wang L, Edel MJ, Carlée L,
Hernandez M and Bernards R: The human tumor antigen PRAME is a
dominant repressor of retinoic acid receptor signaling. Cell.
122:835–847. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Whitehurst AW, Xie Y, Purinton SC, Cappell
KM, Swanik JT, Larson B, Girard L, Schorge JO and White MA: Tumor
antigen acrosin binding protein normalizes mitotic spindle function
to promote cancer cell proliferation. Cancer Res. 70:7652–7661.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cappell KM, Sinnott R, Taus P, Maxfield K,
Scarbrough M and Whitehurst AW: Multiple cancer testis antigens
function to support tumor cell mitotic fidelity. Mol Cell Biol.
32:4131–4140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shang B, Gao A, Pan Y, Zhang G, Tu J, Zhou
Y, Yang P, Cao Z, Wei Q, Ding Y, et al: CT45A1 acts as a new
proto-oncogene to trigger tumorigenesis and cancer metastasis. Cell
Death Dis. 5:e12852014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai S, He B and Wilson EM: Melanoma
antigen gene protein MAGE-11 regulates androgen receptor function
by modulating the interdomain interaction. Mol Cell Biol.
25:1238–1257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Monte M, Simonatto M, Peche LY, Bublik DR,
Gobessi S, Pierotti MA, Rodolfo M and Schneider C: MAGE-A tumor
antigens target p53 transactivation function through histone
deacetylase recruitment and confer resistance to chemotherapeutic
agents. Proc Natl Acad Sci USA. 103:11160–11165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cilensek ZM, Yehiely F, Kular RK and Deiss
LP: A member of the GAGE family of tumor antigens is an
anti-apoptotic gene that confers resistance to Fas/CD95/APO-1,
Interferon-gamma, taxol and gamma-irradiation. Cancer Biol Ther.
1:380–387. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hamer G, Gell K, Kouznetsova A, Novak I,
Benavente R and Höög C: Characterization of a novel
meiosis-specific protein within the central element of the
synaptonemal complex. J Cell Sci. 119:4025–4032. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D'Arcy P, Maruwge W, Wolahan B, Ma L and
Brodin B: Oncogenic functions of the cancer-testis antigen SSX on
the proliferation, survival, and signaling pathways of cancer
cells. PLoS One. 9:e951362014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lee SY, Obata Y, Yoshida M, Stockert E,
Williamson B, Jungbluth AA, Chen YT, Old LJ and Scanlan MJ:
Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA.
100:2651–2656. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim YD, Park HR, Song MH, Shin DH, Lee CH,
Lee MK and Lee SY: Pattern of cancer/testis antigen expression in
lung cancer patients. Int J Mol Med. 29:656–662. 2012.PubMed/NCBI
|
|
25
|
Park JH, Song MH, Lee CH, Lee MK, Park YM,
Old L and Lee SY: Expression of the human cancer/testis antigen
NY-SAR-35 is activated by CpG island hypomethylation. Biotechnol
Lett. 33:1085–1091. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng YH, Wong EW and Cheng CY:
Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis.
Spermatogenesis. 1:209–220. 2011. View Article : Google Scholar
|
|
27
|
Caballero OL and Chen YT: Cancer/testis
(CT) antigens: Potential targets for immunotherapy. Cancer Sci.
100:2014–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
